PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsVulvovaginal candidiasis
MeSH D002181 - vulvovaginal candidiasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D014848:Vulvovaginitis
0 Companies
0 Drugs
Success rate
D002177:Candidiasis
$
Success rate
D002181: 
Vulvovaginal candidiasis
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AAIPharmaKetoconazole Ketoconazole  1999-07-27   
Accord HealthcareItraconazole Itraconazole  2016-05-26   
AkornNystatin Nystatin  1994-02-28   
Alembic PharmaceuticalsItraconazole Itraconazole  2016-12-13   
Nystatin, Triamcinolone Nystatin Triamcinolone  2021-03-31   
Alkem LaboratoriesItraconazole Itraconazole  2017-06-12   
AllerganClotrimazole, Betamethasone Clotrimazole Betamethasone  2002-08-02   
Miconazole M-zole 7 Dual Pack  1997-07-17   
Miconazole Miconazole  1993-11-19   
Nystatin Nystatin  1982-01-01   
AlmirallKetoconazole Xolegel  2006-07-28   
AlpharmaNystatin Mykinac  1982-07-29   
Nystatin Nystatin  1985-10-29   
Nystatin, Triamcinolone Nystatin Triamcinolone  1988-12-20   
Amneal PharmaceuticalsItraconazole Itraconazole  2016-09-26   
Nystatin, Triamcinolone Nystatin Triamcinolone  2018-02-15   
ANI PharmaceuticalsFluconazole Fluconazole  2004-07-29   
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
100%
5/5
Phase 2
70%
7/10
Phase 3
78%
21/27
Approved: 13Overall Success rate: 54%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Bayer
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use